PEAK6 Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-16,921
Closed -$1.39M 4678
2018
Q1
$1.31M Buy
+16,921
New +$1.36M 0.01% 1713
2017
Q2
Sell
-37,675
Closed -$3.07M 4796
2017
Q1
$3.17M Buy
37,675
+15,330
+69% +$1.23M 0.03% 826
2016
Q4
$1.64M Buy
+22,345
New +$1.66M 0.01% 1470
2016
Q2
Sell
-40,576
Closed -$3.05M 4568
2016
Q1
$2.92M Buy
+40,576
New +$3.07M 0.02% 925
2015
Q4
Sell
-104,450
Closed -$8.67M 5043
2015
Q3
$8.74M Buy
+104,450
New +$8.82M 0.05% 541
2015
Q2
Sell
-112,689
Closed -$8.59M 5270
2015
Q1
$8.19M Buy
112,689
+72,813
+183% +$5.18M 0.06% 414
2014
Q4
$2.75M Sell
39,876
-45,230
-53% -$3.05M 0.02% 1058
2014
Q3
$5.52M Sell
85,106
-1,748
-2% -$111K 0.04% 597
2014
Q2
$5.4M Buy
+86,854
New +$5.18M 0.05% 489
2014
Q1
Sell
-2,381
Closed -$133K 5165
2013
Q4
$121K Sell
2,381
-44,019
-95% -$2.2M ﹤0.01% 3910
2013
Q3
$1.17M Buy
46,400
+38,400
+480% +$2.01M 0.01% 2023
2013
Q2
$393 Buy
+8,000
New +$435K ﹤0.01% 3025

Other funds holding LLY

PEAK6 Group's LLY Position: Q2 2018 in Review

PEAK6 Group sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 16,921 shares — an estimated $1.39M sold.

PEAK6 Group first reported a position in LLY in Q2 2013 and held it in 12 quarters. The position peaked at $8.74M in Q3 2015. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • PEAK6 Group reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 16,921 Eli Lilly shares in Q2 2018, an estimated $1.39M.
  • PEAK6 Group first reported a position in Eli Lilly in Q2 2013 and held it in 12 quarters.
  • PEAK6 Group's Eli Lilly position peaked at $8.74M in Q3 2015.
  • 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.